Has Peter Tsai, MD received payments from drug or device companies?

Yes. Drug and device makers reported $51,258 in general payments to Peter Tsai, MD across 391 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peter Tsai, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peter Tsai, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peter Tsai, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Honolulu, HINPI 1265684583

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $34,598 of the $51,258 with a category attached, or 67.5%. It is spread thinly across 32 manufacturers, the largest accounting for just 18.9%. Reporting peaked in 2019 at $12,218 and has fallen 60.8% since, to $4,784 in 2025.

$51,258in general payments, 2019–2025

Across 391 payments — averaging $131.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Atricure, Inc.$10K
Abiomed$9K
Medtronic$7K
Kls-martin L.p.$5K
Artivion, Inc.$5K
Abbott$4K
plus $11K from 26 others

What the payments were for

Speaking & faculty fees$4551%
Travel & lodging$16,04231%
Food & beverage$34,59867%
Education$1630%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Atricure, Inc.	68	$9,699
Abiomed	48	$8,806
Medtronic(2 entities)	62	$7,289
Kls-martin L.p.	23	$5,014
Artivion, Inc.	31	$4,711
Abbott	38	$4,241
Edwards Lifesciences	18	$2,077
Corcym Inc	17	$1,897
Johnson & Johnson(2 entities)	19	$1,001
Angiodynamics, Inc.	6	$818
Bolton Medical Inc	4	$608
Smith+Nephew	5	$575
W. L. Gore & Associates, Inc.	4	$556
E.r. Squibb & Sons, L.L.C.	5	$536
Biosense Webster, Inc.	4	$461
Livanova USA, Inc.	7	$403
Zimmer Biomet	4	$324
Biom'up SA	2	$292
LSI Solutions Inc	2	$256
Boston Scientific	2	$225
Philips North America LLC	2	$204
Biom'up France SAS	1	$198
Dilon Technologies, Inc.	1	$179
Heartflow, Inc.	1	$166
Elevate Surgical Co	2	$148
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	3	$139
Boehringer Ingelheim	1	$125
Novartis	4	$119
Davol Inc.	2	$76
Amgen	2	$52
Lemaitre Vascular, Inc.	2	$38
Bayer	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Impella$7,621
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$4,045
ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER$2,560
HeartWare HVAD$2,165
ATRICLIP LAA EXCLUSION SYSTEM$2,001
Avalus$1,874
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$1,720
Cardiac non-SynerGraft$1,435
Perceval$1,335
BIOGLUE SURGICAL ADHESIVE$1,320
CRYOVALVE SG PULMONARY HUMAN HEART VALVE$1,251
Epic$1,165
AngioVac$818
PHOTOFIX DECELLULARIZED BOVINE PERICARDIUM$751
Penditure$594
Mosaic$542
SAPIEN 3 Ultra RESILIA$489
INSPIRIS RESILIA aortic valve$480
RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$458
BioGlue$451

How this compares

Too few thoracic surgery (cardiothoracic vascular surgery) providers in Hawaiito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$65,675

Medicare patients

Services billed

179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Honolulu

Taryne ImaiHonolulu$114K
Jonathan PhilpottHonolulu$84K
Nicholas DangHonolulu$19K
Jeffrey LauHonolulu$13K
Dean NakamuraHonolulu$11K
Jeffrey WuHonolulu$9K
Ayman Abdul GhaniHonolulu$8K
Jama JahanyarHonolulu$6K
Eric ChungHonolulu$2K
Tracy DorheimHonolulu$953

See the full list for Hawaii →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →